Credit Agricole SA (ACA)
Euronext Paris · France · prices in EUR · close of 23 Oct 2026
Key indicators
| Last close | EUR 14.92 |
|---|---|
| 52-week range | 14.69 – 20.40 |
| Return, 1 month / 3 months | −14.3% / −14.3% |
| Return, 1 year / 3 years | +0.9% / +67.1% |
| Trend | Below its 200-day average |
| RSI (14) | 22 |
| Volatility (1 year) | 21.6% |
| Worst drawdown (1 year) | -23.8% |
| Average daily value traded | 85.62M EUR |
| Dividend yield | 11.4% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Credit Agricole is a French banking group built around a network of cooperative regional banks that serve farmers, households and small businesses, mainly in France. It offers deposit accounts, loans, savings products and insurance through those local branches, and it also runs retail banking outside France. Alongside this, the group provides asset management, leasing and consumer credit, and corporate and investment banking services to companies and institutional clients, with its head office in Paris.
The shares are listed on the Euronext Paris in France under the code ACA, and the price on this page is in euros (EUR). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Credit Agricole SA (ACA) trades on the Euronext Paris in France. It last closed at EUR 14.92 on 23 October 2026.
Its price-based Market X-Ray is 73 out of 100 (a strong price profile), ranking 74 of 625 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 0.9% and over the last three months it fell 14.3%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Euronext Paris
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 61 · Fair | Mixed trend against its averages. | |
| Above 200-day average | -9.5% | ||
| From 52-week high | -26.1% | ||
| Momentum | 60 · Fair | Typical recent returns for this exchange. | |
| 3-month return | -14.3% | ||
| 6-month return | -3.8% | ||
| 12-month return, skipping the last month | 17.7% | ||
| Stability (higher is calmer) | 80 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 21.6% | ||
| Worst drawdown, 1 year (smaller is calmer) | -23.8% | ||
| Liquidity | 97 · Strong | Trades actively. | |
| Average daily value traded | 85.62M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 77 · Strong | Dividend is high and has been paid regularly. | |
| Dividend yield | 11.4% | ||
| Years with dividends | 5 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
- Liquidity: Trades actively.
- Income: Dividend is high and has been paid regularly.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | −5.1% |
|---|---|
| 1 month | −14.3% |
| 3 months | −14.3% |
| 6 months | −3.8% |
| 1 year | +0.9% |
| 3 years | +67.1% |
| 5 years | +76.5% |
Signals
| 50-day / 200-day average | 17.18 / 16.49 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.34 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 13 Oct 2026 | EUR 0.5700 |
| 26 May 2026 | EUR 1.1300 |
| 26 May 2025 | EUR 1.1000 |
| 29 May 2024 | EUR 1.0500 |
| 30 May 2023 | EUR 1.0500 |
| 30 May 2022 | EUR 1.0500 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Euronext Paris; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.